Liquid Biopsy Market Growth, And Opportunities (2023-2030)

Frequently Asked Questions

What is market size of global Liquid Biopsy Market?
The Global liquid biopsy market was valued at US$ 4.3 Billion in 2022, and is projected to reach US$ 7.96 Billion by 2030
What is the CAGR of the Liquid Biopsy Market?
Global Liquid Biopsy Market Is Exhibiting A CAGR Of 23.4% during the Forecast Period.
Which region had major share in the global Liquid Biopsy Market?
North America holds the major share in global Liquid Biopsy Market.
What are the key players in the Liquid Biopsy Market?
QIAGEN,Myriad Genetics, Inc.,BIOCEPT, Inc.,Guardant Health, Inc.,F. Hoffmann-La Roche Ltd.,Illumina, Inc.,Angle plc,Oncimmune,Thermo Fisher Scientific, Inc.,Lucence health Inc.,FreenomeHoldings, Inc.,EPIGENOMICS AG